In this setting of PTEN loss, the mice first developed low-grade glioma at early stages and glioblastoma at later stages: during the late stages of tumor progression the acquisition of molecular abnormalities similar to those observed in proneural glioblastomas are detected. This evidence concerns the gene PTEN and central nervous system cancer.